tradingkey.logo
搜尋

Kiniksa Pharmaceuticals International PLC

KNSA
添加自選
79.150USD
+15.615+24.58%
收盤 07-28 16:00美東報價延遲15分鐘
6.04B總市值
81.35本益比TTM

Kiniksa Pharmaceuticals International PLC

79.150
+15.615+24.58%

KNSA 財務數據

透過專為投資者打造的一站式數據看板,全面查看 Kiniksa Pharmaceuticals International PLC 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。

Kiniksa Pharmaceuticals International PLC財報日曆

最新發布
7月 28, 2026
每股收益 / 預測值
0.33/0.30
營業收入 / 預測值
243.60M/225.46M
報告期
FY2025 財報
營業收入(YoY)
677.56M
60.09%
每股收益(YoY)
0.80
231.50%
分析師評級
BUY
2026/07/28
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
財務指標
每股收益
35.01%0.33
151.20%0.30
252.05%0.19
239.43%0.25
541.17%0.24
146.89%0.12
-134.27%-0.12
10.35%-0.18
-125.70%-0.06
-42.49%-0.25
459.63%0.36
---0.20
--0.21
---0.18
--0.06
----
----
----
----
----
營業收入
55.36%243.60M
55.51%214.27M
64.95%202.13M
61.17%180.85M
44.34%156.80M
72.54%137.78M
46.93%122.54M
67.37%112.21M
51.99%108.63M
65.18%79.86M
34.76%83.39M
-32.37%67.05M
164.99%71.47M
50.19%48.34M
230.14%61.88M
719.64%99.14M
250.10%26.97M
--32.19M
--18.75M
--12.10M
淨利潤
42.62%25.43M
164.57%22.59M
259.75%14.20M
245.24%18.43M
556.29%17.83M
148.23%8.54M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.70M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
112.28%4.46M
833.67%224.09M
51.93%-19.98M
49.05%-25.21M
32.29%-36.33M
30.32%-30.54M
利潤率
-8.20%10.44%
70.14%10.54%
196.85%7.02%
190.11%10.19%
416.13%11.37%
127.95%6.20%
-123.97%-7.25%
45.26%-11.31%
-117.17%-3.60%
12.65%-22.17%
319.80%30.26%
---20.66%
--20.95%
---25.38%
--7.21%
----
----
----
----
----
毛利率
2.48%90.32%
3.75%90.29%
4.97%89.64%
8.19%88.80%
-0.59%88.14%
0.33%87.03%
-3.52%85.40%
-5.05%82.08%
-0.64%88.66%
1.52%86.75%
-0.73%88.51%
--86.45%
--89.23%
--85.45%
--89.16%
----
----
----
----
----
營業收入
55.36%243.60M
55.51%214.27M
64.95%202.13M
61.17%180.85M
44.34%156.80M
72.54%137.78M
46.93%122.54M
67.37%112.21M
51.99%108.63M
65.18%79.86M
34.76%83.39M
-32.37%67.05M
164.99%71.47M
50.19%48.34M
230.14%61.88M
719.64%99.14M
250.10%26.97M
--32.19M
--18.75M
--12.10M
營業利潤
34.89%27.19M
120.52%29.27M
202.43%19.77M
348.72%24.02M
17330.77%20.16M
180.23%13.27M
-23925.93%-19.30M
11.61%-9.66M
96.29%-117.00K
-47.75%-16.54M
-98.66%81.00K
-123.54%-10.93M
83.72%-3.15M
51.99%-11.20M
116.74%6.05M
251.35%46.41M
52.24%-19.37M
52.68%-23.32M
31.70%-36.13M
29.04%-30.67M
淨利潤
42.62%25.43M
164.57%22.59M
259.75%14.20M
245.24%18.43M
556.29%17.83M
148.23%8.54M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.70M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
112.28%4.46M
833.67%224.09M
51.93%-19.98M
49.05%-25.21M
32.29%-36.33M
30.32%-30.54M
流動資產
59.08%668.63M
66.95%594.17M
58.88%527.18M
52.76%475.53M
39.63%420.31M
31.53%355.91M
20.09%331.80M
21.55%311.30M
22.35%301.02M
16.89%270.59M
13.67%276.30M
5.91%256.11M
36.74%246.04M
16.47%231.50M
23.73%243.06M
11.17%241.81M
-26.50%179.94M
-27.87%198.76M
-41.05%196.45M
-42.52%217.51M
流動負債總額
45.34%171.25M
61.01%156.61M
38.33%139.18M
28.80%123.59M
39.79%117.83M
51.48%97.27M
58.05%100.62M
79.46%95.95M
77.56%84.29M
75.50%64.21M
35.27%63.67M
-5.35%53.47M
9.02%47.47M
-27.34%36.59M
5.00%47.07M
64.09%56.49M
12.28%43.54M
42.03%50.35M
40.75%44.82M
38.31%34.43M
總資產
35.54%896.11M
37.70%825.28M
31.54%763.63M
28.28%712.33M
21.89%661.15M
15.33%599.33M
10.30%580.55M
14.95%555.30M
12.00%542.43M
17.34%519.67M
14.50%526.32M
5.02%483.06M
130.00%484.33M
91.74%442.86M
97.45%459.67M
81.90%459.95M
-24.58%210.58M
-25.77%230.97M
-33.38%232.80M
-34.22%252.86M
總負債
45.63%241.96M
54.82%219.59M
37.93%196.03M
49.59%176.95M
54.79%166.14M
61.59%141.84M
62.45%142.12M
51.78%118.29M
47.69%107.33M
66.35%87.78M
37.72%87.48M
2.62%77.94M
27.32%72.68M
-18.47%52.77M
33.00%63.52M
95.68%75.94M
31.46%57.08M
59.96%64.72M
27.27%47.76M
49.83%38.81M
總權益
32.15%654.15M
32.39%605.69M
29.46%567.61M
22.51%535.38M
13.77%495.01M
5.93%457.49M
-0.09%438.44M
7.87%437.01M
5.69%435.10M
10.72%431.89M
10.78%438.84M
5.50%405.13M
168.19%411.66M
134.65%390.10M
114.09%396.15M
79.40%384.01M
-34.90%153.49M
-38.59%166.24M
-40.68%185.04M
-40.29%214.05M
經營淨額
68.01%47.20M
124.87%50.20M
187.13%53.89M
1606.13%33.68M
443.54%28.09M
459.92%22.32M
333.99%18.77M
-113.16%-2.24M
238.07%5.17M
193.44%3.99M
137.36%4.33M
-72.63%16.99M
52.16%-3.74M
88.42%-4.27M
38.70%-11.58M
317.66%62.05M
79.83%-7.82M
8.17%-36.85M
54.16%-18.88M
16.93%-28.51M
投資淨額
-1794.93%-73.58M
38.08%-31.92M
-208.46%-70.81M
-888.58%-62.76M
91.70%-3.88M
-301.93%-51.54M
538.38%65.29M
48.29%-6.35M
-231.70%-46.80M
167.31%25.52M
65.09%-14.89M
-164.48%-12.28M
-7.14%35.53M
-66.88%-37.92M
14.75%-42.66M
-60.21%19.04M
-55.50%38.27M
-150.68%-22.72M
-172.90%-50.04M
131.97%47.85M
融資淨額
13.20%12.11M
119.40%6.07M
257.52%7.66M
77.89%11.90M
6110.11%10.70M
-23.39%2.77M
208.20%2.14M
1111.78%6.69M
-212.66%-178.00K
3914.44%3.61M
-41.60%695.00K
52.91%552.00K
-70.85%158.00K
-78.72%90.00K
-1.82%1.19M
-86.53%361.00K
-38.90%542.00K
-61.75%423.00K
70.22%1.21M
-98.17%2.68M

常見問題

Kiniksa Pharmaceuticals International PLC的總收入是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,總收入達到677.56M(同比變化423.24M)。

Kiniksa Pharmaceuticals International PLC的流動資產是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,流動資產為527.18M(同比變化58.88)。

Kiniksa Pharmaceuticals International PLC的總資產是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,Kiniksa Pharmaceuticals International PLC的總資產為763.63M(同比變化31.54)。

Kiniksa Pharmaceuticals International PLC的總負債是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,Kiniksa Pharmaceuticals International PLC的總責任為196.03M(同比變化37.93)。

Kiniksa Pharmaceuticals International PLC的總權益是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,Kiniksa Pharmaceuticals International PLC的總權益為567.61M(同比變化29.46)。

Kiniksa Pharmaceuticals International PLC的淨營業收入是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,Kiniksa Pharmaceuticals International PLC的淨營業收入為77.22M(同比變化269.28)。

Kiniksa Pharmaceuticals International PLC的淨投資是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,Kiniksa Pharmaceuticals International PLC的淨投資為-188.99M(同比變化-601.68)。

Kiniksa Pharmaceuticals International PLC的淨融資是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,Kiniksa Pharmaceuticals International PLC的淨融資為33.02M(同比變化169.22)。

Kiniksa Pharmaceuticals International PLC的每股收益(EPS)是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,每股收益(EPS)為0.80(同比變化231.50)。

Kiniksa Pharmaceuticals International PLC的淨利潤是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,淨利潤為59.01M(同比變化236.61)。

Kiniksa Pharmaceuticals International PLC的淨利潤率是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,淨利潤率為8.71(同比變化185.33)。

Kiniksa Pharmaceuticals International PLC的毛利率是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,毛利率為88.54(同比變化3.42)。

Kiniksa Pharmaceuticals International PLC的股東權益回報率(ROE)是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,股東權益回報率(ROE)為11.73(同比變化219.12)。

Kiniksa Pharmaceuticals International PLC的資產回報率(ROA)是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,資產回報率(ROA)為8.78(同比變化212.49)。

Kiniksa Pharmaceuticals International PLC的營業利潤是多少?

根據Kiniksa Pharmaceuticals International PLC的FY2025財報,營業利潤為77.22M(同比變化269.28)。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有